59.js","4868","static/chunks/4868-6f49ce1b0a9f5635.js","231","static/chunks/231-4f394f77a0d1e7ca.js","9903","static/chunks/9903-2ec2731c98de1dcf.js","1686","static/chunks/1686-875920cba72b7a2a.js","7239","static/chunks/7239-789f0de8b910cfde.js","1161","static/chunks/1161-02aec766fd43ccf5.js","3188","static/chunks/app/episode/%5BepisodeId%5D/(overview)/page-9786afe733d6104a.js"],"Shownotes"] 16:T542,

Dr. Stringham joined the MacuHealth team after a distinguished career in research and academia. He earned his doctorate in experimental psychology and neuroscience from the University of New Hampshire in 2003, and did postdoctoral training at both Harvard Medical School and the Medical College of Georgia. He has since held positions at the University of Georgia, the Air Force Research Laboratory, and most recently the Duke Eye Center. Nearly all of his research has been geared toward understanding visual and cognitive benefits of the macular carotenoids lutein, zeaxanthin, and meso-zeaxanthin. As the Chief Scientific Officer of MacuHealth, Dr. Stringham will expand the scope of research and application of the macular carotenoids to include investigation of effects that may benefit visual and cognitive performance in athletes, visual and systemic health in those with metabolic disease, and neural health and development in children.

jstringham@macuhealth.com

--------------------------------

For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! Show Sponsors: CooperVision MacuHealth EssilorLuxottica

1f:T542,

EyeCode Media

Overview

Outlines

Mindmap

Transcript

Keywords

Highlights

Shownotes

AI Summary